Virbac’s Otitis Externa Treatment For Dogs Approved In U.S.

he U.S. Food and Drug Administration has approved Virbac Animal Health Inc.’s Easotic (hydrocortisone aceponate, miconazole nitrate, gentamicin sulfate) Suspension for the treatment of otitis externa in dogs.

The U.S. Food and Drug Administration has approved Virbac Animal Health Inc.’s Easotic (hydrocortisone aceponate, miconazole nitrate, gentamicin sulfate) Suspension for the treatment of otitis externa in dogs.

The FDA approved the drug for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius). Administration of Easotic includes instilling 1 mL of the drug in the affected ear once daily for five days. Each milliliter contains 1.11 mg of hydrocortisone aceponate, 15.1 mg of miconazole nitrate, and 1,505 micrograms of gentamicin sulfate.

Virbac, based in Fort Worth, Texas, launched Easotic in Europe in 2009, where it is sold in an airless pump bottle.

<Home>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.